Basic Information
RNALocate ID: | RLID:11001269 |
RNA Symbol: | hsa-miR-197-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-197-3p |
RNA ID: | miRBase:MIMAT0000227 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23382797 |
Tissue/Cell Line: | Brain tissue |
Method: | Microarray |
Description: | We performed miRNA expression analysis using a FlexMAP3D instrument by (Luminex Corporation, Austin, TX) and a manufacturer's assay for 312 miRNA (Table S1). Data are collected from Table S1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001554 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001555 | Mitochondrion | Myotube | 27396686 |
RLID:01001556 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001557 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001558 | Nucleus | Neural progenitor cells | 21363885 |
RLID:11001264 | Exosome | Pooled sera | 27278097 |
RLID:11001265 | Exosome | Primary ovarian tumor cells|Serum | 18589210 |
RLID:11001266 | Exosome | Peripheral blood mononuclear cells | 19002258 |
RLID:11001267 | Exosome | B cell line (Raji)|Jurkat-derived T cell line (J77cl20) | 21505438 |
RLID:11001268 | Exosome | Ovarian follicular fluid | 22116803 |
RLID:11001270 | Exosome | Plasma | 23663360 |
RLID:11001271 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11001272 | Microvesicle | Seminal plasma | 23539611 |
RLID:11001273 | Microvesicle | Follicular fluid | 23666971 |
RLID-D:11000038 | Exosome | B lymphoblastoid cells|Endothelial cells | |
RLID-D:11000306 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-197-3p | Oral squamous cell carcinoma | MNDR-E-MI-24305 |
MNDR | hsa-miR-197-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-24306 |
MNDR | hsa-miR-197-3p | Lymphoma | MNDR-E-MI-24307 |
MNDR | hsa-miR-197-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-24308 |
MNDR | hsa-miR-197-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-24309 |
MNDR | hsa-miR-197-3p | Her2-receptor positive breast cancer | MNDR-E-MI-24310 |
MNDR | hsa-miR-197-3p | Anencephaly | MNDR-E-MI-24311 |
MNDR | hsa-miR-197-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-24312 |
MNDR | hsa-miR-197-3p | Dermatomyositis | MNDR-E-MI-24313 |
MNDR | hsa-miR-197-3p | Prostate cancer | MNDR-E-MI-24314 |
MNDR | hsa-miR-197-3p | Gastric cancer | MNDR-E-MI-24315 |
MNDR | hsa-miR-197-3p | Alzheimer disease | MNDR-E-MI-24316 |
MNDR | hsa-miR-197-3p | Intracranial aneurysm | MNDR-E-MI-24317 |
MNDR | hsa-miR-197-3p | Dysautonomia familial | MNDR-E-MI-24318 |
MNDR | hsa-miR-197-3p | Muscular dystrophy duchenne | MNDR-E-MI-24319 |
MNDR | hsa-miR-197-3p | Primary biliary cirrhosis | MNDR-E-MI-24320 |
MNDR | hsa-miR-197-3p | Graves disease | MNDR-E-MI-24321 |
MNDR | hsa-miR-197-3p | Leukemia | MNDR-E-MI-24322 |
MNDR | hsa-miR-197-3p | Huntington disease | MNDR-E-MI-24323 |
MNDR | hsa-miR-197-3p | Chorea | MNDR-E-MI-24324 |
MNDR | hsa-miR-197-3p | Cardiovascular disease | MNDR-E-MI-24325 |
MNDR | hsa-miR-197-3p | Moyamoya disease | MNDR-E-MI-24326 |
MNDR | hsa-miR-197-3p | Uterine fibroid | MNDR-E-MI-24327 |
MNDR | hsa-miR-197-3p | Lung cancer | MNDR-E-MI-24328 |
MNDR | hsa-miR-197-3p | Down syndrome | MNDR-E-MI-24329 |
MNDR | hsa-miR-197-3p | Parkinson disease | MNDR-E-MI-24330 |
MNDR | hsa-miR-197-3p | Breast cancer | MNDR-E-MI-24331 |
MNDR | hsa-miR-197-3p | Pancreatic cancer | MNDR-E-MI-24332 |
MNDR | hsa-miR-197-3p | Melanoma | MNDR-E-MI-24333 |
MNDR | hsa-miR-197-3p | Rectum adenocarcinoma | MNDR-E-MI-24334 |
MNDR | hsa-miR-197-3p | Nephroblastoma | MNDR-E-MI-24335 |
MNDR | hsa-miR-197-3p | Colon cancer | MNDR-E-MI-24336 |
MNDR | hsa-miR-197-3p | Colon adenocarcinoma | MNDR-E-MI-24337 |
MNDR | hsa-miR-197-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-24338 |
MNDR | hsa-miR-197-3p | Familial ovarian cancer | MNDR-E-MI-24339 |
MNDR | hsa-miR-197-3p | Prostate adenocarcinoma | MNDR-E-MI-24340 |
MNDR | hsa-miR-197-3p | Kidney cancer | MNDR-E-MI-24341 |
MNDR | hsa-miR-197-3p | Carcinoma ductal breast | MNDR-E-MI-24342 |
MNDR | hsa-miR-197-3p | Glioblastoma | MNDR-E-MI-24343 |
MNDR | hsa-miR-197-3p | Astrocytoma | MNDR-E-MI-24344 |
MNDR | hsa-miR-197-3p | Glioma | MNDR-E-MI-24345 |
MNDR | hsa-miR-197-3p | Chronic obstructive pulmonary disease | MNDR-E-MI-24346 |
MNDR | hsa-miR-197-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-24347 |
MNDR | hsa-miR-197-3p | Epilepsy temporal lobe | MNDR-E-MI-24348 |
MNDR | hsa-miR-197-3p | Osteosarcoma | MNDR-E-MI-24349 |
MNDR | hsa-miR-197-3p | Liposarcoma | MNDR-E-MI-24350 |
MNDR | hsa-miR-197-3p | Coronary artery disease | MNDR-E-MI-24351 |
MNDR | hsa-miR-197-3p | Inclusion body myositis | MNDR-E-MI-24352 |
MNDR | hsa-miR-197-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-24353 |
MNDR | hsa-miR-197-3p | Liver cancer | MNDR-E-MI-24354 |
MNDR | hsa-miR-197-3p | Uterine cancer | MNDR-E-MI-24355 |
MNDR | hsa-miR-197-3p | Gastric adenocarcinoma | MNDR-E-MI-24356 |
MNDR | hsa-miR-197-3p | Bone-invasive pituitary adenoma | MNDR-E-MI-24357 |
MNDR | hsa-miR-197-3p | Lung squamous cell carcinoma | MNDR-E-MI-24358 |
MNDR | hsa-miR-197-3p | Carcinoma lung non-small-cell | MNDR-E-MI-24359 |
MNDR | hsa-miR-197-3p | Lung adenocarcinoma | MNDR-E-MI-24360 |
MNDR | hsa-miR-197-3p | Follicular thyroid carcinoma | MNDR-E-MI-24361 |
MNDR | hsa-miR-197-3p | Thyroid carcinoma | MNDR-E-MI-24362 |
MNDR | hsa-miR-197-3p | Pancreatic adenocarcinoma | MNDR-E-MI-24363 |
MNDR | hsa-miR-197-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-24364 |
MNDR | hsa-miR-197-3p | Kidney renal clear cell carcinoma | MNDR-E-MI-24365 |
MNDR | hsa-miR-197-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-24366 |
MNDR | hsa-miR-197-3p | Clear cell renal cell carcinoma | MNDR-E-MI-24367 |
MNDR | hsa-miR-197-3p | Cholangiocarcinoma | MNDR-E-MI-24368 |
MNDR | hsa-miR-197-3p | Esophageal cancer | MNDR-E-MI-24369 |
MNDR | hsa-miR-197-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-24370 |
MNDR | hsa-miR-197-3p | Encephalomyelitis | MNDR-E-MI-24371 |
MNDR | hsa-miR-197-3p | Breast invasive carcinoma | MNDR-E-MI-24372 |
MNDR | hsa-miR-197-3p | Hepatocellular carcinoma | MNDR-E-MI-24373 |
MNDR | hsa-miR-197-3p | Familiar ovarian carcinoma | MNDR-E-MI-24374 |
MNDR | hsa-miR-197-3p | B-cell lymphoma | MNDR-E-MI-24375 |
MNDR | hsa-miR-197-3p | Rheumatoid arthritis | MNDR-E-MI-24376 |
MNDR | hsa-miR-197-3p | Neuroblastoma | MNDR-E-MI-24377 |
MNDR | hsa-miR-197-3p | Barrett's adenocarcinoma | MNDR-E-MI-24378 |
MNDR | hsa-miR-197-3p | Burkitt lymphoma | MNDR-E-MI-24379 |
MNDR | hsa-miR-197-3p | Neuromyelitis optica | MNDR-E-MI-24380 |
MNDR | hsa-miR-197-3p | Psoriasis | MNDR-E-MI-24381 |
MNDR | hsa-miR-197-3p | Skin cutaneous melanoma | MNDR-E-MI-24382 |
MNDR | hsa-miR-197-3p | Skin melanoma | MNDR-E-MI-24383 |
MNDR | hsa-miR-197-3p | Acute myelocytic leukemia | MNDR-E-MI-24384 |
MNDR | hsa-miR-197-3p | Colorectal cancer | MNDR-E-MI-24385 |
MNDR | hsa-miR-197-3p | Nasopharynx carcinoma | MNDR-E-MI-24386 |
MNDR | hsa-miR-197-3p | Acute lymphocytic leukemia | MNDR-E-MI-24387 |
MNDR | hsa-miR-197-3p | Nasopharyngeal cancer | MNDR-E-MI-24388 |
MNDR | hsa-miR-197-3p | Hypersomnolence idiopathic | MNDR-E-MI-24389 |
MNDR | hsa-miR-197-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-24390 |
MNDR | hsa-miR-197-3p | Pancreatitis chronic | MNDR-E-MI-24391 |
MNDR | hsa-miR-197-3p | Barrett's carcinogenesis | MNDR-E-MI-24392 |
MNDR | hsa-miR-197-3p | Breast cancer her3+ negative | MNDR-E-MI-24393 |
MNDR | hsa-miR-197-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-24394 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ACVR1 | Homo sapiens | RR00038744 |
TOP